Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Reba

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragmentK Yokoyama, J C Reynolds, C H Paik, et al.
Orthopedics|November 1, 1989
The use of indium-111 labeled platelet scanning for the detection of asymptomatic deep venous thrombosis in a high risk populationR S Siegel, J L Rae, N L Ryan, et al.
Circulation|June 1, 1983
Insensitivity of the cold pressor stimulation test for the diagnosis of coronary artery diseaseA G Wasserman, L Reiss, R J Katz, et al.
Journal of Medicinal Chemistry|October 1, 1991
Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetatesV I Cohen, R E Gibson, L H Fan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1989
In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilateR E Gibson, T A Schneidau, V I Cohen, et al.
Journal of Medicinal Chemistry|September 1, 1982
Analogues of 3-quinuclidinyl benzilateW J Rzeszotarski, R E Gibson, W C Eckelman, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
Receptor-selective localization in pancreasR E Gibson, W C Eckelman, R C Reba, et al.
Journal of Pharmaceutical Sciences|April 1, 1992
Synthesis and receptor affinities of new 3-quinuclidinyl alpha-heteroaryl-alpha-aryl-alpha-hydroxyacetatesV I Cohen, R E Gibson, L H Fan, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementiaD R Weinberger, D Jones, R C Reba, et al.
Life Sciences|January 1, 1993
A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtypeM S Gitler, V I Cohen, R De la Cruz, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragmentK Yokoyama, J C Reynolds, C H Paik, et al.
Orthopedics|November 1, 1989
The use of indium-111 labeled platelet scanning for the detection of asymptomatic deep venous thrombosis in a high risk populationR S Siegel, J L Rae, N L Ryan, et al.
Circulation|June 1, 1983
Insensitivity of the cold pressor stimulation test for the diagnosis of coronary artery diseaseA G Wasserman, L Reiss, R J Katz, et al.
Journal of Medicinal Chemistry|October 1, 1991
Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetatesV I Cohen, R E Gibson, L H Fan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1989
In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilateR E Gibson, T A Schneidau, V I Cohen, et al.
Journal of Medicinal Chemistry|September 1, 1982
Analogues of 3-quinuclidinyl benzilateW J Rzeszotarski, R E Gibson, W C Eckelman, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
Receptor-selective localization in pancreasR E Gibson, W C Eckelman, R C Reba, et al.
Journal of Pharmaceutical Sciences|April 1, 1992
Synthesis and receptor affinities of new 3-quinuclidinyl alpha-heteroaryl-alpha-aryl-alpha-hydroxyacetatesV I Cohen, R E Gibson, L H Fan, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementiaD R Weinberger, D Jones, R C Reba, et al.
Life Sciences|January 1, 1993
A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtypeM S Gitler, V I Cohen, R De la Cruz, et al.
Pageof 17